PRMT5 regulating mechanisms involve CDK4-activity34; more recently BCR-signaling in germinal center B cells and in cases of diffuse large B cell lymphoma (DLBCL) has been described to trigger increased PRMT5 expression35. This evidence concerns the gene CDK4 and diffuse large B-cell lymphoma.